144 related articles for article (PubMed ID: 2282123)
1. Alternative approach to relative bioavailability and bioequivalence evaluation, with drugs following Michaelis-Menten elimination kinetics.
Fagiolino P; Stareczek S
Farmaco; 1990 Sep; 45(9):1027-36. PubMed ID: 2282123
[TBL] [Abstract][Full Text] [Related]
2. Influence of bioavailability on the calculated Michaelis-Menten parameters of phenytoin in children.
Koren G; Brand N; MacLeod SM
Ther Drug Monit; 1984; 6(1):11-4. PubMed ID: 6710554
[TBL] [Abstract][Full Text] [Related]
3. Variation of the peak concentration following single and repeated drug administrations in investigations of bioavailability and bioequivalence.
Zha J; Endrenyi L
J Biopharm Stat; 1997 Mar; 7(1):191-204. PubMed ID: 9056598
[TBL] [Abstract][Full Text] [Related]
4. Linear relationships in systems with non linear kinetics.
Fagiolino P; Savio E; Stareczek S
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():485-96. PubMed ID: 1820928
[TBL] [Abstract][Full Text] [Related]
5. Phenytoin bioavailability assessed by steady state serum concentrations.
Halkin H; Gapany M; Dinai Y; Dany S
Isr J Med Sci; 1985 Apr; 21(4):327-30. PubMed ID: 3997495
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability/bioequivalence of modified release drug delivery systems: which pharmacokinetic parameters to determine, single or multiple dose studies, pretests, conditions and other aspects.
Ritschel WA
Methods Find Exp Clin Pharmacol; 1992; 14(6):469-82. PubMed ID: 1469957
[No Abstract] [Full Text] [Related]
7. Pharmacokinetics and bioequivalence of different formulations of pirenzepine.
Vergin H; Mascher H; Strobel K; Nitsche V
Arzneimittelforschung; 1986 Sep; 36(9):1409-12. PubMed ID: 3790194
[TBL] [Abstract][Full Text] [Related]
8. Use of a programmable calculator to determine steady-state levels of drugs eliminated by parallel first-order and Michaelis-Menten kinetics.
Crow JW; Levy G
Am J Hosp Pharm; 1978 Sep; 35(9):1075-7. PubMed ID: 696752
[TBL] [Abstract][Full Text] [Related]
9. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
[TBL] [Abstract][Full Text] [Related]
10. [Bioequivalence of enteric coated tablet of Zhengqing Fengtongning].
Zhang SH; Zhou YD; He HX
Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(6):683-5. PubMed ID: 18590201
[TBL] [Abstract][Full Text] [Related]
11. Comparing the concentration curves directly in a pharmacokinetics, bioavailability/bioequivalence study.
Liao JJ
Stat Med; 2005 Mar; 24(6):883-91. PubMed ID: 15558699
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability and bioequivalence trials: statistics & pharmacokinetic principles.
Rajaram L; Roy SK; Skerjanec A
Stud Health Technol Inform; 2004; 103():159-79. PubMed ID: 15747918
[TBL] [Abstract][Full Text] [Related]
13. Effect of doses on the bioavailability of phenytoin from a prompt-release and an extended-release preparation: single dose study.
Rojanasthien N; Chaichana N; Teekachunhatean S; Kumsorn B; Sangdee C; Chankrachang S
J Med Assoc Thai; 2007 Sep; 90(9):1883-93. PubMed ID: 17957935
[TBL] [Abstract][Full Text] [Related]
14. Individualizing phenytoin dosage regimens using a programmable calculator.
Ng PK
Am J Hosp Pharm; 1980 Apr; 37(4):529-33. PubMed ID: 7377216
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of adimolol after single and multiple dose administration in healthy volunteers.
Wiedemann I; Peil H; Justus H; Adamus S; Brantl V; Lohmann H
Arzneimittelforschung; 1985; 35(6):964-9. PubMed ID: 2862877
[TBL] [Abstract][Full Text] [Related]
16. [Population kinetic program for Michaelis-Menten elimination].
Lü M; Zhou HW; Song JF
Zhongguo Yao Li Xue Bao; 1990 Jan; 11(1):85-8. PubMed ID: 2403022
[TBL] [Abstract][Full Text] [Related]
17. [Review and use of decision rules for bioequivalence trials].
Nicolas P; Tod M; Petitjean O
Therapie; 1993; 48(1):15-22. PubMed ID: 8356540
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetics and bioequivalence of various oral formulations of metoclopramide].
Vergin H; Bishop-Freudling GB; Strobel K; Reeves DS
Arzneimittelforschung; 1983; 33(3):458-62. PubMed ID: 6683523
[TBL] [Abstract][Full Text] [Related]
19. [A simulation study on the characteristics in a steady-state for Michaelis-Menten elimination kinetics].
Zhou HW; Jing RR; Qiu ZQ
Zhongguo Yao Li Xue Bao; 1986 Nov; 7(6):483-8. PubMed ID: 2955636
[No Abstract] [Full Text] [Related]
20. KINPAK--a program for standardized pharmacokinetic analysis.
Kaufmann B
Methods Find Exp Clin Pharmacol; 1986 Oct; 8(10):615-24. PubMed ID: 3784699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
